Patents matching “cisplatin”

US 11013740

Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

The Board of Regents of the University of Texas System · Granted May 25, 2021 · Expires May 20, 2041

US 10272084

Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

US 8703756

Synthetic procedure and cancer treatment with cisplatin derivatives

THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Apr 22, 2014 · Expires Apr 17, 2034

EP 2678011

ANTITUMORIGENE KOMBINATON, DIE CABAZITAXEL UND CISPLATIN UMFASST

AVENTIS PHARMA SA [FR] · Granted Jan 1, 2014 · Expires Dec 27, 2033

EP 2620148

Antitumorkombination mit Cabazitaxel und Cisplatin

AVENTIS PHARMA SA [FR] · Granted Jul 31, 2013 · Expires Jul 26, 2033

EP 2491925

Antitumorigene Kombinaton, die Cabazitaxel und Cisplatin umfasst

AVENTIS PHARMA SA [FR] · Granted Aug 29, 2012 · Expires Aug 24, 2032

US 7700134

Prevention of cisplatin induced deafness

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 20, 2010 · Expires Apr 15, 2030